Correction: Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Correction: Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers ; volume:43 ; number:25 ; day:29 ; month:5 ; year:2024 ; pages:1972 ; date:6.2024
Oncogene ; 43, Heft 25 (29.5.2024), 1972, 6.2024
- Urheber
-
Sun, Bowen
Mason, Seth
Wilson, Robert C.
Hazard, Starr E.
Wang, Yubao
Fang, Rong
Wang, Qiwei
Yeh, Elizabeth S.
Yang, Meixiang
Roberts, Thomas M.
Zhao, Jean J.
Wang, Qi
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41388-024-02999-1
- URN
-
urn:nbn:de:101:1-2408210856289.213333301444
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
2025-08-14T10:50:58+0200
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sun, Bowen
- Mason, Seth
- Wilson, Robert C.
- Hazard, Starr E.
- Wang, Yubao
- Fang, Rong
- Wang, Qiwei
- Yeh, Elizabeth S.
- Yang, Meixiang
- Roberts, Thomas M.
- Zhao, Jean J.
- Wang, Qi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers
Bioprocessing technologies in biorefinery for sustainable production of fuels, chemicals, and polymers
Job change in urban China : an assessment of socialist employment relationship
Stability of numerical solution for partial differential equations with piecewise constant arguments
Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers
The landscape of d16HER2 splice variant expression across HER2-positive cancers
Targeting HER3 or MEK overcomes acquired Trastuzumab resistance in HER2-positive gastric cancer-derived xenograft
New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth
Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers
San cai tu hui : 106 juan, 21
San cai tu hui : 106 juan, 6
Return Migration of Foreign Students
Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers
Bioprocessing technologies in biorefinery for sustainable production of fuels, chemicals, and polymers
Job change in urban China : an assessment of socialist employment relationship
Stability of numerical solution for partial differential equations with piecewise constant arguments
Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers
The landscape of d16HER2 splice variant expression across HER2-positive cancers
Targeting HER3 or MEK overcomes acquired Trastuzumab resistance in HER2-positive gastric cancer-derived xenograft
New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth
Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers
San cai tu hui : 106 juan, 21
San cai tu hui : 106 juan, 6
Return Migration of Foreign Students
Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers
Bioprocessing technologies in biorefinery for sustainable production of fuels, chemicals, and polymers
Job change in urban China : an assessment of socialist employment relationship
Stability of numerical solution for partial differential equations with piecewise constant arguments
Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers
The landscape of d16HER2 splice variant expression across HER2-positive cancers
Targeting HER3 or MEK overcomes acquired Trastuzumab resistance in HER2-positive gastric cancer-derived xenograft
New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth
Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers
San cai tu hui : 106 juan, 21
San cai tu hui : 106 juan, 6